IGFBP7 Antikörper (C-Term)
Kurzübersicht für IGFBP7 Antikörper (C-Term) (ABIN7185037)
Target
Alle IGFBP7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human IGFBP7.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC:1:100-1:300, ELISA:1:40000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
-
Andere Bezeichnung
- IGFBP7
-
Hintergrund
- AGM antibody, Angiomodulin antibody, FSTL2 antibody, IBP-7 antibody, IBP7 antibody, IBP7_HUMAN antibody, IGF binding protein 7 antibody, IGF-binding protein 7 antibody, IGFBP rP1 antibody, IGFBP-7 antibody, IGFBP-rP1 antibody, IGFBP7 antibody, IGFBPRP1 antibody, Insulin like growth factor binding protein 7 antibody, Insulin-like growth factor-binding protein 7 antibody, MAC25 antibody, MAC25 protein antibody, PGI2 stimulating factor antibody, PGI2-stimulating factor antibody, Prostacyclin stimulating factor antibody, Prostacyclin-stimulating factor antibody, PSF antibody, RAMSVPS antibody, TAF antibody, Tumor-derived adhesion factor antibody
-
UniProt
- Q16270
-
Pathways
- Growth Factor Binding
Target
-